Clinical Characteristics And Outcome Of COVID-19 Infection In Patients With Chronic Respiratory Diseases.

NCT05054127 | Unknown

• 1 other identifier: COVID-19 and CRD
• Study Type: observational
• Target: 100
• Locations: 0 countries
• Sites: N/A

Brief Summary

1. 1.To identify the pattern of presentation of COVID-19 in patients with chronic respiratory diseases
2. 2.To asses the severity of COVID-19 in patients with chronic respiratory diseases
3. 3.To identify the outcome of COVID-19 in patients with chronic respiratory diseases

Conditions

Covid19; Chronic Respiratory Disease

Outcome Measures

Primary Outcomes (1)

• relation between covid 19 and patients with chronic respiratory diseases

  pattern of presentation of COVID-19 in patients with chronic respiratory diseases 2-To asses the severity of COVID-19 in patients with chronic respiratory diseases 3-To identify the outcome of COVID-19 in patients with chronic respiratory diseases The pattern of presentation of COVID-19 in patients with chronic respiratory diseases The severity of COVID-19 in patients with chronic respiratory diseases The outcome of COVID-19 in patients with chronic respiratory diseases

  Baseline

Interventions

foiiow up patients OTHER

observational study

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

patients with chronic respiratory diseases present with covid 19 infection

You may qualify if:

• patients with chronic respiratory diseases diagnosed with covid-19 infection by PCR
• Patients aged 18 years and above

You may not qualify if:

• Patient aged below 18 years old.
• Patients refuse to share in our study

Sponsors & Collaborators

• Assiut University: lead

Related Publications (3)

• Cakir Edis E. Chronic Pulmonary Diseases and COVID-19. Turk Thorac J. 2020 Sep;21(5):345-349. doi: 10.5152/TurkThoracJ.2020.20091. Epub 2020 Sep 1.

  PMID: 33031727 BACKGROUND

• Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS, Quaderi S, Mandal S, Hurst JR. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PLoS One. 2020 May 11;15(5):e0233147. doi: 10.1371/journal.pone.0233147. eCollection 2020.

  PMID: 32392262 BACKGROUND

• Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F, Jeanpierre E, Rauch A, Labreuche J, Susen S; Lille ICU Haemostasis COVID-19 Group. Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence. Circulation. 2020 Jul 14;142(2):184-186. doi: 10.1161/CIRCULATIONAHA.120.047430. Epub 2020 Apr 24. No abstract available.

  PMID: 32330083 BACKGROUND

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Central Study Contacts

Reham El Morshedy, lecturer

CONTACT

01065060672; reham1715@gmail.com

Marwan Mohammed, lecturer

CONTACT

01009364307; lilamarwan2016@gmail.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 12 Months
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Madonna youssef roshdy kelada

Study Record Dates

• First Submitted: September 21, 2021
• First Posted: September 23, 2021
• Study Start: April 15, 2022
• Primary Completion: April 15, 2022
• Study Completion: May 15, 2023
• Last Updated: February 24, 2022

Record last verified: 2022-02